Detalhe da pesquisa
1.
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Int J Cancer
; 153(7): 1413-1422, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424386
2.
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
BMC Cancer
; 23(1): 205, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870947
3.
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.
Clin Cancer Res
; 27(22): 6106-6114, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475104